Pharmanutra Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	14.77	15.62	18.93	22.05	29.41	16.46
Short-Term Investments	7.2	13.48	6.19	4.81	4.53	4.35
Cash & Short-Term Investments	21.97	29.1	25.12	26.86	33.94	20.8
Cash Growth	-9.98%	15.84%	-6.49%	-20.86%	63.14%	10.50%
Accounts Receivable	26.94	22.05	19.22	21.65	16.67	15.05
Other Receivables	0.72	2.1	2.7	2.12	0.99	1.87
Receivables	27.66	24.15	21.92	23.77	17.66	16.92
Inventory	10.23	6.94	8.17	5.26	2.87	1.89
Prepaid Expenses	-	0.68	1.06	0.93	0.15	-
Other Current Assets	8.23	4.14	2.42	1.9	0.9	0.79
Total Current Assets	68.09	65.01	58.68	58.73	55.52	40.41
Property, Plant & Equipment	24.29	25.66	26.36	17.06	8.37	4.8
Long-Term Investments	0	0	0	0	0.25	0.25
Goodwill	-	17.62	17.56	17.56	2.75	2.75
Other Intangible Assets	24.38	3.71	3.73	3.15	2.45	2.43
Long-Term Deferred Tax Assets	1.43	1.4	1.52	1.31	1.24	0.85
Long-Term Deferred Charges	-	0.67	0.08	-	-	-
Other Long-Term Assets	1.58	3.39	4.5	2.36	0.77	0.22
Total Assets	119.77	117.47	112.44	100.16	71.36	51.71
Accounts Payable	17.7	13.5	13.66	14.89	8.49	6.38
Accrued Expenses	-	3.81	3.23	2.83	2.6	2.35
Short-Term Debt	0.08	0.41	0.63	-	-	-
Current Portion of Long-Term Debt	4.54	4.04	3.59	3.37	0.56	0.88
Current Portion of Leases	0.37	0.32	0.37	0.25	0.26	0.22
Current Income Taxes Payable	4.45	1.96	2.18	0.98	2.92	0.05
Current Unearned Revenue	-	2.3	2.45	2	1.26	0.8
Other Current Liabilities	3.95	1.02	1.55	1.48	0.66	0.47
Total Current Liabilities	31.09	27.34	27.65	25.79	16.75	11.14
Long-Term Debt	14.89	18.15	22.19	13.61	5	0.31
Long-Term Leases	1.11	1.36	1.24	0.5	0.53	0.25
Pension & Post-Retirement Benefits	5.26	1.33	1.21	1.07	2.52	1.26
Other Long-Term Liabilities	1.36	7.09	5.75	8.23	1.48	1.02
Total Liabilities	53.71	55.27	58.04	49.21	26.27	13.98
Common Stock	1.12	1.12	1.12	1.12	1.12	1.12
Retained Earnings	14.01	16.61	12.83	15.27	14	14.3
Treasury Stock	-5.17	-4.56	-4.01	-	-	-
Comprehensive Income & Other	56.1	49.03	44.47	34.55	29.96	22.31
Shareholders' Equity	66.07	62.2	54.41	50.95	45.08	37.73
Total Liabilities & Equity	119.77	117.47	112.44	100.16	71.36	51.71
Total Debt	20.98	24.27	28.02	17.73	6.35	1.66
Net Cash (Debt)	0.98	4.83	-2.9	9.14	27.59	19.14
Net Cash Growth	-	-	-	-66.89%	44.14%	54.06%
Net Cash Per Share	0.10	0.50	-0.30	0.94	2.85	1.98
Filing Date Shares Outstanding	9.65	9.6	9.61	9.62	9.68	9.68
Total Common Shares Outstanding	9.65	9.6	9.61	9.64	9.68	9.68
Working Capital	36.99	37.67	31.03	32.94	38.77	29.26
Book Value Per Share	6.85	6.48	5.66	5.28	4.66	3.90
Tangible Book Value	41.69	40.86	33.11	30.24	39.88	32.55
Tangible Book Value Per Share	4.32	4.26	3.44	3.14	4.12	3.36
Land	-	20.65	20.42	0.75	0.64	0.64
Machinery	-	7.61	6.86	3.26	2.85	2.13
Construction In Progress	-	0.16	0.13	14.92	6.14	3.28

Source: S&P Global Market Intelligence. Standard template. Financial Sources.